Timing and Outcomes of Recovery After intraCerebral Hemorrhage
Condition(s) studied
Investigational drug(s) / intervention(s)
Surgical interventions: By leveraging a wide array of surgical interventions - including endoscopic surgery, minimally invasive surgery combined with urokinase, and craniotomy - the TORCH registry intends to provide a granular view of early hematoma evacuation surgical interventions and their impact on patient recovery and quality of life.
Study summary
The TORCH registry is a prospective, observational cohort study, which will collect detailed, longitudinal data on the clinical characteristics, treatment modalities, and outcomes of patients with ICH. By leveraging a wide array of surgical interventions - including endoscopic surgery, minimally invasive surgery combined with urokinase, and craniotomy - the TORCH registry intends to provide a granular view of early hematoma evacuation surgical interventions and their impact on patient recovery and quality of life.
Eligibility
Primary outcome measure(s)
- Functional Outcome — 6 months after onset
modified Rankin Score (mRS) 0=no symptoms, 1=no significant disability, 2=slight disability, 3= moderate disability, 4=moderate severe disability, 5=severe disability, 6=death
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| The Department of Neurosurgery, China International Neuroscience Institute, Xuanwu Hospital, Capital Medical University, | Beijing | China | Recruiting |
More Xuanwu Hospital, Beijing trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07166146 on ClinicalTrials.gov ↗ ← All trials in China